Yang Y.-L.CHIEN-CHING HUNGWang A.-H.Tseng F.-C.Leaw S.N.Tseng Y.-T.Su C.-L.Chen H.-T.Lauderdale T.-L.Lo H.-J.2021-12-012021-12-0120100095-1137https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954449741&doi=10.1128%2fJCM.00500-10&partnerID=40&md5=32f220731e26d7e9606e128d9a7b960ehttps://scholars.lib.ntu.edu.tw/handle/123456789/588890Among 234 isolates comprising 26 different Candida species colonizing the oropharynx of 181 (54.3% of 399 surveyed) HIV-infected outpatients, 27 (11.7%) were fluconazole resistant. Antibacterial treatment was associated with increased rates of yeast colonization, while antiretroviral therapy and pneumococcal vaccination protected patients from yeast colonization. Copyright ? 2010, American Society for Microbiology. All Rights Reserved.[SDGs]SDG3amphotericin B; fluconazole; fungus antibody; Pneumococcus vaccine; antifungal agent; fluconazole; antibiotic therapy; antifungal resistance; article; Candida albicans; Candida dubliniensis; Candida tropicalis; candidemia; CD4 lymphocyte count; cohort analysis; fungal colonization; fungus identification; fungus isolation; high risk patient; highly active antiretroviral therapy; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; minimum inhibitory concentration; mucocutaneous candidiasis; oropharynx candidiasis; outpatient; prevalence; priority journal; prospective study; Taiwan; vaccination; virus load; adult; Candida; complication; drug effects; female; heterozygote; HIV Infections; isolation and purification; male; microbial sensitivity test; microbiology; middle aged; oropharynx; risk factor; statistical model; Candida; Adult; Antifungal Agents; Candida; Carrier State; Cohort Studies; Drug Resistance, Fungal; Female; Fluconazole; HIV Infections; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Oropharynx; Outpatients; Risk Factors; Taiwanjournal article10.1128/JCM.00500-10204449702-s2.0-77954449741